Borrelia immunoassays and materials therefor

    公开(公告)号:US11209431B2

    公开(公告)日:2021-12-28

    申请号:US15766525

    申请日:2016-10-06

    摘要: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.

    MULTIPLEX HEPATITIS B ASSAY
    7.
    发明申请
    MULTIPLEX HEPATITIS B ASSAY 有权
    多重HEPATITIS B测定

    公开(公告)号:US20140323332A1

    公开(公告)日:2014-10-30

    申请号:US14261525

    申请日:2014-04-25

    IPC分类号: G01N33/576

    CPC分类号: G01N33/5761 G01N33/54326

    摘要: Provided herein are multiplex assays for determining whether an individual is or has been infected with Hepatitis B virus, and the stage of infection or resolution. In addition, the multiplex system can discriminate between vaccinated subjects and subjects susceptible to Hepatitis B infection.

    摘要翻译: 本文提供用于确定个体是否已经感染乙型肝炎病毒的多重测定,以及感染或分辨的阶段。 此外,多重系统可以区分接种的受试者和易感乙型肝炎感染的受试者。